Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000186620 | SCV000167797 | benign | not specified | 2013-05-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000723806 | SCV000202517 | uncertain significance | not provided | 2014-01-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000186620 | SCV000312069 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000313460 | SCV000467277 | uncertain significance | Cortical dysplasia-focal epilepsy syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000368109 | SCV000467278 | uncertain significance | Pitt-Hopkins-like syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000186620 | SCV000594170 | likely benign | not specified | 2016-12-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000313460 | SCV000766454 | likely benign | Cortical dysplasia-focal epilepsy syndrome | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312828 | SCV000847833 | likely benign | Inborn genetic diseases | 2016-09-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000723806 | SCV001929085 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000723806 | SCV001976219 | likely benign | not provided | no assertion criteria provided | clinical testing |